Evidence map›Paper›PMID 39732781›Full record

ArticleScientific reports2024

Active plasma sterilizer for planetary protection and contamination control for space missions.

Subrata Roy, Justin Kosky, Tamara Revazishvili, Sarthak Roy, Sierra Brown, Vladimir Vichnyakov, Nona Rurua, Emma Noelle Mastro, Davit Kobaidze

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Subrata RoySurfPlasma, Inc., Gainesville, FL, 32601, USA. subrata@surfplasma.com.
Justin KoskySurfPlasma, Inc., Gainesville, FL, 32601, USA.
Tamara RevazishviliEmerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.
Sarthak RoySurfPlasma, Inc., Gainesville, FL, 32601, USA.
Sierra BrownSurfPlasma, Inc., Gainesville, FL, 32601, USA.
Vladimir VichnyakovSurfPlasma, Inc., Gainesville, FL, 32601, USA.
Nona RuruaEmerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.
Emma Noelle MastroSurfPlasma, Inc., Gainesville, FL, 32601, USA.
Davit KobaidzeEmerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.

Funding

NASA 80NSSC22CA132
6 · The paper itself

Abstract

This paper introduces a novel, compact plasma sterilization system, the Active Plasma Sterilizer (APS), for planetary protection space missions. The development of the APS system is done through iterative testing and design modifications aimed at addressing decontamination modalities for time and temperature, cleaning adhesive surfaces, and cleaning protocols beyond alcohol and bleach. Decontamination testing of Deinococcus radiodurans, Geobacillus stearothermophilus (spore forming bacteria), and Aspergillus fumigatus (fungi) was verified for the APS on relevant materials of 4 to 5 log reduction up to complete killing in 45 min or less. The material compatibility testing of the APS performed with Stainless Steel 316, Teflon PTFE, and FR-4 PCB using a single exposure showed no visible material degradation through SEM analysis. This study demonstrates the efficacy of the APS technology for use with planetary protection due to its low-temperature operation, low weight and size, zero-plumbing requirements, safety features, decontamination capabilities, and material compatibility.

Indexed as

DecontaminationSpace FlightSterilizationAspergillus fumigatusGeobacillus stearothermophilusPlasma GasesPlasma GasesOzonePlasmaPlumbing-free designPortableSmartSterilization

Identifiers

PMID39732781
PMCPMC11682346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.